Humanized Anti-CD28 Recombinant Antibody (clone Lulizumab) (CAT#: TAB-H46)

• Antigen-Specific Responses
  Lulizumab has been crucial in studying antigen-specific T-cell responses. It helps understand how CD28 co-stimulation influences T-cell responses to specific antigens, aiding targeted immunotherapy research.
• Advanced Metabolic Studies
  Lulizumab has facilitated detailed studies on T-cell metabolism. Engaging CD28 allowed us to explore metabolic pathways crucial for T-cell function and proliferation.
• Crucial for Autoimmune Research
  Lulizumab has been essential in our autoimmune disease research. It helped explore CD28 signaling's role in autoimmunity, providing valuable insights into disease mechanisms.

1. Q 1: In what ways does lulizumab advance our understanding of T-cell metabolism?

   A: By engaging CD28, Lulizumab enables researchers to investigate metabolic shifts in T-cells during activation, shedding light on the metabolic pathways crucial for T-cell function and proliferation.

2. Q 2: Which extra safety measures need to be taken when working with lulizumab in a laboratory setting?

   A: Handle the antibody gently to maintain its integrity. Store aliquots at -20°C or lower, and protect from prolonged exposure to light to preserve its functional activity.

3. Q 3: Is it possible to use lollisumab for T-cell analysis using flow cytometry?

   A: Lulizumab can be used in flow cytometry to detect CD28 expression on T-cells.

View the frequently asked questions answered by Creative Biolabs Support.